ELV - Tracking Jeremy Grantham's GMO Capital Portfolio - Q1 2024 Update

2024-05-22 20:25:32 ET

Summary

• Jeremy Grantham's 13F portfolio value increased from $22.66B to $27.52B this quarter.
• The largest five stakes in the portfolio are Microsoft Corporation, Alphabet, Meta Platforms, UnitedHealth, and Apple.
• GMO's 7-year asset class real return forecast ranges from a negative 4.9% for US Large Cap to a positive 3.9% for Emerging Value.

This article is part of a series that provides an ongoing analysis of the changes made to GMO’s 13F stock portfolio on a quarterly basis. It is based on GMO’s regulatory 13F Form filed on 5/14/2024. Jeremy Grantham’s 13F portfolio value increased from $22.66B to $27.52B this quarter. The portfolio is diversified with recent 13F reports showing well over 500 different positions although most of them are very small. There are 34 securities that are significantly large (more than 0.5% of the portfolio each) and they are the focus of this article. The largest five stakes are Microsoft Corporation, Alphabet, Meta Platforms, UnitedHealth, and Apple. They add up to ~19% of the portfolio. Please visit our Tracking Jeremy Grantham’s GMO Portfolio series to get an idea of their investment philosophy and our last report for the fund’s moves during Q4 2023....

For further details see: